Physiological Reviews,
Journal Year:
2023,
Volume and Issue:
103(4), P. 2847 - 2892
Published: July 13, 2023
The
kidneys
play
a
key
role
in
maintaining
total
body
homeostasis.
complexity
of
this
task
is
reflected
the
unique
architecture
organ.
Ureteral
obstruction
greatly
affects
renal
physiology
by
altering
hemodynamics,
changing
glomerular
filtration
and
metabolism,
inducing
architectural
malformations
kidney
parenchyma,
most
importantly
fibrosis.
Persisting
pathological
changes
lead
to
chronic
disease,
which
currently
∼10%
global
population
one
major
causes
death
worldwide.
Studies
on
consequences
ureteral
date
back
1800s.
Even
today,
experimental
unilateral
(UUO)
remains
standard
model
for
tubulointerstitial
However,
has
certain
limitations
when
it
comes
studying
tubular
injury
repair,
as
well
limited
potential
human
translation.
Nevertheless,
provided
scientific
community
with
wealth
knowledge
(patho)physiology.
With
introduction
advanced
omics
techniques,
classical
UUO
remained
relevant
day
been
instrumental
understanding
fibrosis
at
molecular,
genomic,
cellular
levels.
This
review
details
concepts
recent
advances
obstructive
nephropathy,
highlighting
pathophysiological
hallmarks
responsible
functional
induced
obstruction,
special
emphasis
Journal of Leukocyte Biology,
Journal Year:
2020,
Volume and Issue:
108(3), P. 787 - 799
Published: March 17, 2020
Abstract
ICAM-1
is
a
cell
surface
glycoprotein
and
an
adhesion
receptor
that
best
known
for
regulating
leukocyte
recruitment
from
circulation
to
sites
of
inflammation.
However,
in
addition
vascular
endothelial
cells,
expression
also
robustly
induced
on
epithelial
immune
cells
response
inflammatory
stimulation.
Importantly,
serves
as
biosensor
transduce
outside-in-signaling
via
association
its
cytoplasmic
domain
with
the
actin
cytoskeleton
following
ligand
engagement
extracellular
domain.
Thus,
has
emerged
master
regulator
many
essential
cellular
functions
both
at
onset
resolution
pathologic
conditions.
Because
role
driving
responses
well
recognized,
this
review
will
mainly
focus
newly
emerging
roles
injury-resolution
responses,
effector
function
inflammation
tumorigenesis.
been
clinical
therapeutic
interest
some
time
now;
however,
several
attempts
inhibiting
improve
injury
have
failed.
Perhaps,
better
understanding
beneficial
or
tumorigenesis
spark
new
revisiting
value
potential
target.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: March 17, 2023
Abstract
Chronic
kidney
disease
(CKD)
is
estimated
to
affect
10–14%
of
global
population.
Kidney
fibrosis,
characterized
by
excessive
extracellular
matrix
deposition
leading
scarring,
a
hallmark
manifestation
in
different
progressive
CKD;
However,
at
present
no
antifibrotic
therapies
against
CKD
exist.
fibrosis
identified
tubule
atrophy,
interstitial
chronic
inflammation
and
fibrogenesis,
glomerulosclerosis,
vascular
rarefaction.
Fibrotic
niche,
where
organ
initiates,
complex
interplay
between
injured
parenchyma
(like
tubular
cells)
multiple
non-parenchymal
cell
lineages
(immune
mesenchymal
located
spatially
within
scarring
areas.
Although
the
mechanisms
are
complicated
due
kinds
cells
involved,
with
help
single-cell
technology,
many
key
questions
have
been
explored,
such
as
what
kind
renal
tubules
profibrotic,
myofibroblasts
originate,
which
immune
how
communicate
each
other.
In
addition,
genetics
epigenetics
deeper
that
regulate
fibrosis.
And
reversible
nature
epigenetic
changes
including
DNA
methylation,
RNA
interference,
chromatin
remodeling,
gives
an
opportunity
stop
or
reverse
therapeutic
strategies.
More
marketed
(e.g.,
RAS
blockage,
SGLT2
inhibitors)
developed
delay
progression
recent
years.
Furthermore,
better
understanding
also
favored
discover
biomarkers
fibrotic
injury.
review,
we
update
advances
mechanism
summarize
novel
treatment
for
CKD.
Signal Transduction and Targeted Therapy,
Journal Year:
2022,
Volume and Issue:
7(1)
Published: June 9, 2022
Abstract
Chronic
kidney
disease
(CKD)
is
a
chronic
renal
dysfunction
syndrome
that
characterized
by
nephron
loss,
inflammation,
myofibroblasts
activation,
and
extracellular
matrix
(ECM)
deposition.
Lipotoxicity
oxidative
stress
are
the
driving
force
for
loss
of
including
tubules,
glomerulus,
endothelium.
NLRP3
inflammasome
signaling,
MAPK
PI3K/Akt
RAAS
signaling
involves
in
lipotoxicity.
The
upregulated
Nox
expression
decreased
Nrf2
result
directly.
injured
resident
cells
release
proinflammatory
cytokines
chemokines
to
recruit
immune
such
as
macrophages
from
bone
marrow.
NF-κB
JAK-STAT
Toll-like
receptor
cGAS-STING
major
pathways
mediate
inflammation
inflammatory
cells.
produce
secret
great
number
profibrotic
TGF-β1,
Wnt
ligands,
angiotensin
II.
TGF-β
Notch
evoke
activation
promote
generation
ECM.
potential
therapies
targeted
these
also
introduced
here.
In
this
review,
we
update
key
lipotoxicity,
stress,
kidneys
with
injury,
drugs
based
on
latest
studies.
Unifying
will
be
instrumental
advance
further
basic
clinical
investigation
CKD.
Frontiers in Microbiology,
Journal Year:
2020,
Volume and Issue:
11
Published: June 9, 2020
Gut
microbiota,
an
integral
part
of
the
human
body,
comprise
bacteria,
fungi,
archaea,
and
protozoa.
There
is
consensus
that
disruption
gut
microbiota
(termed
“gut
dysbiosis”)
influenced
by
host
genetics,
diet,
antibiotics,
inflammation,
it
closely
linked
to
pathogenesis
inflammatory
diseases,
such
as
obesity
bowel
disease
(IBD).
Macrophages
are
key
players
in
maintenance
tissue
homeostasis
eliminating
invading
pathogens
exhibit
extreme
plasticity
their
phenotypes,
M1
or
M2,
which
have
been
demonstrated
exert
pro-
anti-inflammatory
functions.
Microbiota-derived
metabolites,
short-chain
fatty
acids
(SCFAs)
Gram-negative
bacterial
lipopolysaccharides
(LPS),
pro-inflammatory
effects
acting
on
macrophages.
Understanding
role
macrophages
microbiota-inflammation
interactions
might
provide
us
a
novel
method
for
preventing
treating
diseases.
In
this
review,
we
summarize
recent
research
relationship
between
inflammation
discuss
important
context.
Angewandte Chemie International Edition,
Journal Year:
2019,
Volume and Issue:
59(10), P. 4068 - 4074
Published: Dec. 19, 2019
Atherosclerosis
(AS)
is
a
major
contributor
to
cardiovascular
diseases
worldwide,
and
alleviating
inflammation
promising
strategy
for
AS
treatment.
Here,
we
report
molecularly
engineered
M2
macrophage-derived
exosomes
(M2
Exo)
with
inflammation-tropism
anti-inflammatory
capabilities
imaging
therapy.
Exo
are
derived
from
macrophages
further
electroporated
FDA-approved
hexyl
5-aminolevulinate
hydrochloride
(HAL).
After
systematic
administration,
the
exhibit
excellent
anti-inflammation
effects
via
surface-bonded
chemokine
receptors
cytokines
released
macrophages.
Moreover,
encapsulated
HAL
can
undergo
intrinsic
biosynthesis
metabolism
of
heme
generate
carbon
monoxide
bilirubin,
which
enhance
finally
alleviate
AS.
Meanwhile,
intermediate
protoporphyrin
IX
(PpIX)
pathway
permits
fluorescence
tracking
Frontiers in Cell and Developmental Biology,
Journal Year:
2020,
Volume and Issue:
8
Published: Feb. 28, 2020
Inflammation
and
fibrosis
are
two
pathological
features
of
chronic
kidney
disease
(CKD).
Transforming
growth
factor-β
(TGF-β)
has
been
long
considered
as
a
key
mediator
renal
fibrosis.
In
addition,
TGF-β
also
acts
potent
anti-inflammatory
cytokine
that
negatively
regulates
inflammation.
Thus,
blockade
inhibits
while
promoting
inflammation,
revealing
diverse
role
for
in
CKD.
It
is
now
well
documented
TGF-β1
activates
its
downstream
signaling
molecules
such
Smad3
Smad3-dependent
non-coding
RNAs
to
transcriptionally
differentially
regulate
inflammation
fibrosis,
which
regulated
by
Smad7.
Therefore,
treatments
rebalancing
Smad3/Smad7
or
specifically
targeting
could
be
better
therapeutic
approach.
this
review,
the
paradoxical
functions
underlying
mechanisms
discussed
novel
strategies
TGF-β/Smad
transcriptomes
highlighted.